Summary by Moomoo AI
AbbVie Inc. officer Perry C Siatias is set to sell 2,919 shares of the company's common stock on February 2, 2024, according to a recent filing. The shares, valued at approximately $496,230, were acquired on the same date through the exercise of stock options, with the issuer being the source of the securities. The transaction involved a cash payment made on the date of acquisition. There have been no other reported sales of securities by Siatias in the past three months, as per the provided documentation.